The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Elfadil, Hassabelrasoul ^a   Fahal, Ahmed ^b   Kloezen, Wendy ^c   Ahmed, Elhadi M ^a   van de Sande, Wendy ^c  

^a UNIVERSITY OF GEZIRA   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACACIA NUBICA EXTRACT; BETA AMYRIN; BETA AMYRONE; BLACK PEPPER EXTRACT; BOSWELLIA PAPYRIFERA EXTRACT; CINNAMOMUM ZEYLANICUM EXTRACT; EUGENIA CARYOPHYLLUS EXTRACT; GINGER EXTRACT; KETOCONAZOLE; NIGELLA SATIVA EXTRACT; PLANT EXTRACT; SITOSTEROL; STIGMATRIENE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ACACIA NUBICA; ANTIFUNGAL ACTIVITY; ARTICLE; BLACK CUMIN; BLACK PEPPER; BOSWELLIA PAPYRIFERA; BROTH DILUTION; CINNAMOMUM ZEYLANICUM; CONTROLLED STUDY; EUGENIA CARYOPHYLLUS; GAS LIQUID CHROMATOGRAPHY; GINGER; IN VITRO STUDY; MADURELLA MYCETOMATIS; MADUROMYCOSIS; MASS SPECTROMETRY; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SUDAN; WOUND HEALING; CHEMISTRY; DRUG EFFECTS; MADURELLA; MASS FRAGMENTOGRAPHY; MICROBIOLOGY; MYCETOMA;

ANTIFUNGAL AGENTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MADURELLA; MYCETOMA; PLANT EXTRACTS; PLANTS, MEDICINAL; SUDAN;

EID: 84928787363     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003488     Document Type: Article

References (40)

1. Fahal AH, . (2013) Mycetoma in Williams, Bulstrode, O’Connell, Bailey and Love’s Short Practice of Surgery 26E: 26th Edition, Oxford University Press, pp 64–68
2. Fahal AH, . (2011) Mycetoma in Richard, Guerrant, Walker, Peter, Tropical Infectious Diseases: Principles, Pathogens and Practice. Third edition, Elsevier Publisher, chapter 83, pp. 565–568. doi: 10.1007/s13197-011-0525-7 24587533
3. Fahal AH, . (2011) Mycetoma. Review article, Khartoum Med J. 4(1): 514–523.
4. Fahal AH, Hassan MA, (1992) Mycetoma. Br J Surg 79(11): 1138–1141. 1467883
5. Fahal AH, (2004) Mycetoma thorn on the flesh. Review article. Trans R Soc Trop Med Hyg 98(1):3–11. 14702833
6. Fahal AH, van de Sandy WW, (2012) The Epidemiology of mycetoma. Curr Fungal Infect Rep 6 (4): 320–326.
7. Van Belkum A, Fahal A, van de Sande WW, (2013) Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma. Adv Exp Med Biol 764:179–189. 23654067
8. Ahmed AA, van de Sande WW, Fahal AH, Bakker-Woudenberg I, Verbrugh H, et al. (2007) Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20(2):146–51. 17496572
9. Ahmed AO, van Leeuwen W, Fahal A, van de Sande WW, Verbrugh H, et al. (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 4(9):566–74 15336224
10. Fahal AH, Elkhawad AO, . (2013) Treating Mycetoma: Guidelines for Best Practice. Expert Rev Dermatol 8(3): 301–307.
11. Fahal AH, . (2010) Management of mycetoma. Expert Rev Dermatol 5(1), 87–93.
12. Zein HAM, Fahal AH, Mahgoub ES, EL Hassan T, Abdel Rahman ME, . (2012) The Predictors of Cure, Amputation & Follow-up dropout among Mycetoma Patients as seen at The Mycetoma Research Centre, University of Khartoum. Trans R Soc Trop Med Hyg. 106(11):639–44. doi: 10.1016/j.trstmh.2012.07.003 22854685
13. Mahgoub ES, Gumaa SA, . (1984) Ketoconazole in the treatment of eumycetoma due to Madurella mycetomi. Trans R Soc Trop Med Hyg 78:376–79. 6087513
14. Fahal AH, Rahman IA, El-Hassan AM, EL Rahman ME, Zijlstra EE, . (2011) The efficacy of itraconazole in the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 105 (3):127–32. doi: 10.1016/j.trstmh.2010.11.008 21247608
15. Wendy Kloezen, Meis Jacques F, Ilse Curfs-Breuker, Ahmed Fahal, van de Sande Wendy WJ, . (2012) In vitro antifungal activity of isavuconazole to Madurella mycetomatis. Antimicrob Agents Chemother. 56(11):6054–6. doi: 10.1128/AAC.01170-12 22964246
16. Ahmed AO, van de Sande WW, van Vianen W, van Belkum A, Fahal AH, et nal. (2004). In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 48(7):2742–6. 15215141
17. van Belkum A, Fahal HA, Wendy van de Sande WW, . (2011) In Vitro Susceptibility of Madurella Mycetomatis to Posaconazole and Terbinafine. Antimicrob Agents Chemother. 55(4):1771–3. doi: 10.1128/AAC.01045-10 21263050
18. van de Sande WW, Fahal AH, Riley TV, Verbrugh H, van Belkum A, . (2007). In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J Antimicrob Chemother. 59(3):553–5. 17324961
19. van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, et al. (2007) Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect. 9: 1114–1123. 17644456
20. Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW, . (2013) A histopathological exploration of the Madurella mycetomatis grain. PLoS One. 8(3):e57774. Epub 2013 Mar 6. doi: 10.1371/journal.pone.0057774 23483927
21. Ezaldeen EA, Fahal AH, Osman A, . (2013) Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience. PLoS Negl Trop Dis 7(8): e2400. doi: 10.1371/journal.pntd.0002400 23991244
22. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa (2002).
23. Raaman N, . (2006) Phytochemical Techniques. New India Publishing Agency, Chapter six, pp. 40–67. doi: 10.1016/j.nepr.2005.06.003 19040854
24. Banso A, . (2009) Phytochemical and antibacterial investigation of bark extract of Acacia nubica. J. Med. Plants Res 3 (2):082–085.
25. Hammer KA, Carson CF, Riley TV, . (2003) Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol. 95: 853–60. 12969301
26. Camarda L, Dayton T, Di Stefano V, Pitonzo R, Schillaci D, . (2007) Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae). Annali di Chimica, 9(97), 837–844. 17970299
27. Abdoul-latif FM, Louis-Clément O, Imael HN, Dicko MH, . (2012) Antimicrobial activities of essential oil and methanol extract of Boswellia sacra Flueck. and Boswellia papyrifera (Del.) Hochst from Djibouti. Int J Mment, Mod Sc Technol 1(1): 1–10.
28. Wesenberg-Ward KE, Tyler BJ, Sears JT, . (2005) Adhesion and biofilm formation of Candida albicans on native and Pluronic-treated polystyrene. Biofilms, 1(2), Biofilms 63–71. Doi: 10.1017/S1479050505001687
29. Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V, . (2008) In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils, Letters in Applied Microbiology 5(47): 433–438. doi: 10.1111/j.1472-765X.2008.02469.x 19146534
30. Al-Fattani MA, Douglas LJ, (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55(8):999–1008.
31. Hostanska K, Daum G, Saller R, (2002) Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res 22:2853–2862. 12530009
32. Ammon HP, Safayi H, Mack T, Sabieraj J, . (1993) Mechanism of anti-inflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 38 (2–3): 113–9. 8099636
33. Fahal AH, El Toum E, El Hassan AM, Mahgoub ES, Gumaa SA, . (1995) The host tissue reaction to Madurella mycetomatis: new classification. J Med Vet Mycol 33(5): 15–17. 8544084
34. Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, et al. (2006) Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol 290(6):1131–7. doi:10.1152/ajpgi.00562
35. Sharma A, Bhatia S, Kharya MD, Gajbhiye V, Ganesh N, et.al. (2010) Anti-inflammatory and analgesic activity of different fractions of Boswellia serrata. Int J Phytomed 1(2): 94–99.
36. Liu M, Chen P, Büchele B, Dong S, Huang D, et al. (2013) A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum. Parasitol Res 112(3):1105–11. doi: 10.1007/s00436–012 23271565
37. Devi PR, Adilaxmamma K, Rao GS, Srilatha Ch, Raj MA, (2012) Safety Evaluation of Alcoholic Extract of Boswellia ovalifoliolata Stem-bark in Rats. Toxicol Int 19(2):115–20. doi: 10.4103/0971-6580.97198 22778507
38. Ahmed M, Al-Daghri N, Alokail MS, Hussain T, (2013) Potential changes in rat spermatogenesis and sperm parameters after inhalation of Boswellia papyrifera and Boswellia carterii incense. Int J Environ Res Public Health 10(3):830. doi: 10.3390/ijerph10030830 23449005
39. Mahmoudi A, Hosseini-Sharifabad A, Monsef-Esfahani HR, Yazdinejad AR, Khanavi M, et al. (2011) Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats. J Nat Med 65(3–4):519–25. doi: 10.1007/s11418-011-0523-0 21479861
40. Singh P, Chacko KM, Aggarwal ML, Bhat B, Khandal RK, et al. 2012. A-90 Day Gavage Safety Assessment of Boswellia serrata in Rats. Toxicol Int 19(3):273–8. doi: 10.4103/0971-6580.103668 23293466